Global Medical REIT Inc. (GMRE) — Financial statements
Income statement, balance sheet, and cash flow for Global Medical REIT Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 148↑7.1% | 138↓1.8% | 141↑2.7% | 137↑18.4% | 116 | |
| Cost of Revenue | 0.00↓100.0% | 29↑4.2% | 28↑11.5% | 25↑62.6% | 15 | |
| Gross Profit | 0.00↓100.0% | 109↓3.3% | 113↑0.8% | 112↑11.6% | 100 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 20↓5.3% | 21↑25.3% | 17↑1.9% | 17↑0.6% | 16 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 20↓5.3% | 21↑25.3% | 17↑1.9% | 17↑0.6% | 16 | |
| Other Expenses | 128↑131.6% | 55↓4.8% | 58↑2.5% | 57↑21.0% | 47 | |
| Operating Expenses | 148↑93.8% | 76↑2.0% | 75↑2.3% | 73↑15.7% | 63 | |
| Total Costs & Expenses | 148↑40.2% | 106↑2.6% | 103↑4.7% | 98↑24.9% | 79 | |
| Operating Results | ||||||
| Operating Income | 0.00↓100.0% | 33↓13.7% | 38↓2.2% | 39↑4.7% | 37 | |
| Depreciation & Amortization | 58↑3.5% | 56↓5.0% | 59↑2.3% | 58↑21.9% | 47 | |
| EBITDA | 78↓15.1% | 91↓18.1% | 112↑8.5% | 103↑20.6% | 85 | |
| EBIT | 20↓44.5% | 35↓32.8% | 53↑16.4% | 45↑18.9% | 38 | |
| Interest & Other Income | ||||||
| Net Interest Income | -32↓10.7% | -29↑7.1% | -31↓22.4% | -25↓28.1% | -20 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 32↑10.7% | 29↓7.1% | 31↑22.4% | 25↑28.1% | 20 | |
| Non-Operating Income | -20↓626.3% | -3↑81.7% | -15↓126.6% | -7↓520.5% | -1 | |
| Other Income / Expenses | 0.00↑100.0% | -26↓61.1% | -16↑13.8% | -19↓0.4% | -19 | |
| Income Before Tax | -12↓281.1% | 7↓69.2% | 22↑8.7% | 20↑9.0% | 18 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -12↓281.1% | 7↓69.2% | 22↑8.7% | 20↑9.0% | 18 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -12↓282.7% | 7↓67.8% | 21↑7.7% | 19↑8.6% | 18 | |
| Bottom-Line Net Income | -12↓1594.0% | 0.81↓94.5% | 15↑11.0% | 13↑12.9% | 12 | |
| EPS (Basic) | -0.91↓393.5% | 0.31↓94.6% | 5.75↑463.7% | 1.02↑5.2% | 0.97 | |
| EPS (Diluted) | -0.91↓393.5% | 0.31↓94.6% | 5.75↑463.7% | 1.02↑220.0% | -0.85 | |
| Weighted Average Shares | 13↑407.3% | 3↑0.6% | 3↑0.1% | 3↑8.0% | 2 | |
| Weighted Average Diluted Shares | 13↑407.3% | 3↑0.6% | 3↑0.1% | 3↑8.0% | 2 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.